Related Experiment Video
Updated: Aug 15, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Medication use during pregnancy for neurologic conditions
J Gilmore1, P B Pennell, B J Stern
1Department of Neurology, Emory University, Atlanta, Georgia 30322, USA.
Managing pregnant patients with neurological conditions like epilepsy or eclampsia requires careful consideration of physiological changes and fetal impact. This guide focuses on medication use and patient care strategies for these complex cases.
Area of Science:
- Neurology
- Obstetrics
- Pharmacology
Background:
- Pregnancy involves significant physiological alterations impacting maternal health.
- Managing neurological disorders during pregnancy presents unique challenges due to potential medication effects on the fetus.
- Existing literature often lacks comprehensive guidance for specific neurological conditions in pregnant individuals.
Purpose of the Study:
- To provide an overview of management strategies for pregnant patients with common neurological disorders.
- To highlight key considerations regarding medication use in this population.
- To suggest evidence-based approaches for patient care.
Main Methods:
- Literature review focusing on epilepsy, eclampsia, stroke, multiple sclerosis, and headache in pregnancy.
- Analysis of current guidelines and research on pharmacotherapy during gestation.
- Synthesis of clinical recommendations for managing these conditions.
Main Results:
- Specific management considerations for epilepsy, eclampsia, stroke, multiple sclerosis, and headache are detailed.
- Emphasis on risk-benefit assessment for various medications.
- Strategies for optimizing patient care and minimizing adverse outcomes are proposed.
Conclusions:
- Effective management of neurological disorders in pregnancy necessitates a multidisciplinary approach.
- Careful medication selection and patient monitoring are crucial for maternal and fetal well-being.
- Further research is needed to refine treatment protocols for specific neurological conditions during pregnancy.
More Related Videos
07:36Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
08:23Adaptation of Microelectrode Array Technology for the Study of Anesthesia-induced Neurotoxicity in the Intact Piglet Brain
Published on: May 12, 2018
Related Concept Videos
Factors Affecting Drug Response: Overview
Mania and Antimanic Drugs: Overview
Antiepileptic Drugs: Glutamate Antagonists
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Drug Therapy
Antianxiety Medications